The UZH Foundation
The UZH Foundation seeks donations and bequests to achieve its fundamental goal of promoting excellence at the University of Zurich. By giving support, you become part of the ground-breaking work done by University of Zurich researchers. Donations to the UZH Foundation accelerate the progress made in research and education, bringing benefits to society at large.
Change in Board of Trustees of UZH Foundation
12.03.2020 – The Board of Trustees of the UZH Foundation has undergone changes. In its first meeting in March 2020, the UZH Foundation thanked and bid farewell to four of its members, who left a mark on the foundation. Despite their departure, the foundation will continue to be able to draw on in-depth expertise and develop further with new board members.
UZH Molecular Biologist Prajwal: Made the Step into Entrepreneurship Thanks to Fellowship
11.03.2019 – UZH molecular biologist Prajwal and a team of researchers have developed a comprehensive rapid diagnostic test for multi-resistant tuberculosis pathogens. Their work was made possible thanks to the UZH Entrepreneur Fellowship, which is financed by the Werner Siemens Foundation and encourages and supports young UZH researchers to transform their scientific knowledge and technologies into commercial enterprises.
UZH Back Among Best 100 Universities of the World
26.09.2018 – The University of Zurich ranks 90th in the latest Times Higher Education (THE) World University Rankings. UZH was able to gain ground in several areas.
Understanding Global Biodiversity Change Better
20.09.2018 – Remote sensing expert Michael Schaepman wants to use a new aerial sensing method to investigate the complex interplay between ecosystems, species and genes. It could help measure global biodiversity. His research project is supported by the NOMIS Foundation with a donation of 5,1 Mio.
UZH Life Sciences Fund invests in Spin-off Anaveon
12 Jun 2018 – Onur Boyman, an immunologist working at the University Hospital Zurich and UZH, has joined forces with Andreas Katopodis to establish Anaveon, a company aiming to translate breakthroughs in research in the field of cytokines into new and innovative immunotherapies for cancer. The spin-off has been made possible thanks to support from the UZH Life Sciences Fund.
